反応式
[CH3:1][C:2]1[C:6]([C:7]2[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=2)=[C:5]([CH3:13])[N:4]([C:14]2[CH:19]=[CH:18][C:17]([CH2:20][CH2:21][NH:22][C:23](=O)[O:24]C3C=CC=CC=3)=[CH:16][CH:15]=2)[N:3]=1.[CH3:32][C:33]1[CH:38]=[C:37]([CH3:39])[N:36]=[C:35]([S:40]([NH2:43])(=[O:42])=[O:41])[N:34]=1>>[CH3:1][C:2]1[C:6]([C:7]2[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=2)=[C:5]([CH3:13])[N:4]([C:14]2[CH:15]=[CH:16][C:17]([CH2:20][CH2:21][NH:22][C:23]([NH:43][S:40]([C:35]3[N:34]=[C:33]([CH3:32])[CH:38]=[C:37]([CH3:39])[N:36]=3)(=[O:41])=[O:42])=[O:24])=[CH:18][CH:19]=2)[N:3]=1参加物
3
実験手順
The title compound was prepared according to the procedure described in step 1 of Example 42 from phenyl 2-[4-(3,5-dimethyl-4-phenyl-1H-pyrazol-1-yl)phenyl]ethylcarbamate (step 1 of Example 22) and 4,6-dimethylpyrimidine-2-sulfonamide: 1H-NMR (CDCl3) δ 7.46-7.23 (10H, m), 6.82 (1H, br.s), 3.54-3.47 (2H, m), 2.89-2.84 (2H, m), 2.58 (6H, s), 2.33 (3H, s), 2.27 (3H, s).
出典と根拠
- ORDレコード
- ord-65ba05726a9948fa968052e7dc018bc1
- 出典データセット
- uspto-grants-2006_02
- 特許番号
- US07001917B2
関連ノート
読み込み中…